Table 4 Progression characteristics of incident exudative nAMD and stratified by drusen subtype.

From: Macular neovascularization in eyes with pachydrusen

 

Progressor (n = 13)

Non progressor (n = 62)

p-value*

Soft drusen (n = 46)

Pachydrusen (n = 29)

Progressor (n = 6)

Non-progressor (n = 40)

p-value

Progressor (n = 7)

Non-progressor (n = 22)

p-value*

Final drusen area

5.0 (4.2)

1.1 (2.0)

0.06

16.4 (7.5)

5.2 (4.6)

0.01

2.1 (1.8)

0.4 (0.5)

0.22

Final SQDA

2.2 (2.6)

1.0 (2.0)

0.06

4.0 (2.3)

1.5 (1.4)

0.01

1.4 (0.8)

0.6 (0.4)

0.22

SQDA change/year

8.8 (4.5)

6.0 (3.6)

0.12

10.9 (6.7)

5.1 (6.0)

0.02

3.8 (4.9)

3.2 (3.8)

0.32

  1. *Kruskal wallis test for comparison of non-parametric variables.